| Literature DB >> 26844829 |
Josiah Gerdts1, Daniel W Summers2, Jeffrey Milbrandt3, Aaron DiAntonio4.
Abstract
Wallerian axon degeneration is a form of programmed subcellular death that promotes axon breakdown in disease and injury. Active degeneration requires SARM1 and MAP kinases, including DLK, while the NAD+ synthetic enzyme NMNAT2 prevents degeneration. New studies reveal that these pathways cooperate in a locally mediated axon destruction program, with NAD+ metabolism playing a central role. Here, we review the biology of Wallerian-type axon degeneration and discuss the most recent findings, with special emphasis on critical signaling events and their potential as therapeutic targets for axonopathy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26844829 PMCID: PMC4742785 DOI: 10.1016/j.neuron.2015.12.023
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173